Question

In: Math

3. A clinical trial examined the effectiveness of aspirin in the treatment of cerebral ischemia(stroke). Patients...

3. A clinical trial examined the effectiveness of aspirin in the treatment of cerebral ischemia(stroke). Patients were randomized into treatment and control groups. The study wasdouble-blind. After six months of treatment, the attending physicians evaluated eachpatient’s progress as either favorable or unfavorable. Of the 78 patients in the aspiringroup, 63 had favorable outcomes; 43 of the 77 control patients had favorable outcomes.(A) The physicians conducting the study had concluded from previous research theaspirin was likely to increase the chance of a favorable outcome. Carry out a significancetest to confirm this conclusion. State the hypotheses, find aP-value, and write a summaryof your results.(B) Estimate the difference between the favorable proportions in the treatment andcontrol groups. Use 95% confidence.

Solutions

Expert Solution

Part A

Here, we have to use z test for difference between population proportions.

Null hypothesis: H0: The aspirin was not likely to increase the chance of favourable outcomes.

Alternative hypothesis: Ha: The aspirin was likely to increase the chance of favourable outcomes.

H0: p1 ≤ p2 versus Ha: p > p2

This is a right tailed or an upper tailed test.

We assume level of significance = α = 0.05

The test statistic formula is given as below:

Z = (P1 – P2) / sqrt(P*(1 – P)*((1/N1) + (1/N2)))

Where,

X1 = 63

X2 = 43

N1 = 78

N2 = 77

P = (X1+X2)/(N1+N2) = (63 + 43) / (78 + 77) = 0.6839

P1 = X1/N1 = 63/78 = 0.807692308

P2 = X2/N2 = 43/77 = 0.558441558

P1 - P2 = 0.807692308 - 0.558441558 = 0.249250749

Z = (P1 – P2) / sqrt(P*(1 – P)*((1/N1) + (1/N2)))

Z = 0.249250749 / sqrt(0.6839*(1 – 0.6839)*((1/78) + (1/77)))

Z = 3.3369

P-value = 0.0004

(by using z-table)

P-value < α = 0.05

So, we reject the null hypothesis

There is sufficient evidence to conclude that the aspirin was likely to increase the chance of favourable outcomes.

Part B

Here, we have to find the 95% confidence interval for difference between two population proportions.

Confidence interval for difference between two population proportions:

Confidence interval = (P1 – P2) ± Z*sqrt[(P1*(1 – P1)/N1) + (P2*(1 – P2)/N2)]

Confidence level = 95%

Critical Z value = 1.96

(by using z-table)

Confidence interval = (P1 – P2) ± Z*sqrt[(P1*(1 – P1)/N1) + (P2*(1 – P2)/N2)]

P1 - P2 = 0.807692308 - 0.558441558 = 0.249250749

Confidence interval = 0.249250749 ± 1.96*sqrt[(0.807692308*(1 – 0.807692308)/78) + (0.558441558*(1 – 0.558441558)/77)]

Confidence interval = 0.249250749 ± 0.1413

Lower limit = 0.249250749 - 0.1413 = 0.1080

Upper limit = 0.249250749 + 0.1413 = 0.3905

Confidence interval = (0.1080, 0.3905)

Confidence interval = (10.8%, 39.1%)


Related Solutions

1. In a clinical trial for the effectiveness of a new treatment for the flu, some...
1. In a clinical trial for the effectiveness of a new treatment for the flu, some people were given the new treatment while others received a placebo, Of the 400 people that were given the new treatment, 300 of them saw improvements. Of the 169 people that received the placebo, 120 saw improvements. Use a 0.05 significance level to test the claim that there is no difference in the proportion of people that saw improvements whether or not they receive...
A clinical trial was conducted to test the effectiveness of a drug for treatment insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treatment insomnia in older subjects. Before treatment, 13 subjects had a mean wake time of 102.0 min. After treatment, the 13 subjects had a mean wake time of 92.4 min and a standard deviation of 22.1 min. Assume that 13 samples value appear to be from a normally distributed population and construct a 99% confidence interval estimate of the mean wake time for a population with drug...
The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly...
The drug ancrod was tested in a double-blind clinical trial in which stroke patients were randomly assigned to receive either ancrod or a placebo. One of the response variables in the study was whether or not the subjects experienced intracranial hemorrhaging. Of the 84 patients who received ancrod, 13 hemorrhaged. Of the 77 patients who received the placebo, only three hemorrhaged. a.Is there a significant difference in hemorrhaging rates between treatments? Show your work and include all steps for full...
Patients in a clinical trial for a new cancer treatment are classified as permanently cured, in remission
Patients in a clinical trial for a new cancer treatment are classified as permanently cured, in remission (the cancer is present, but not growing), sick (the cancer is growing), or deceased. After one year of treatment, 1/3 of sick patients go into remission, another 1/3 are permanently cured, and, unfortunately, 1/3 are deceased. Patients in remission also receive treatment after a year of which 1/4 remain in remission, 1/2 are permanently cured, and 1/4 decline to the sick condition (a) Formulate...
Evaluate the effectiveness of the various treatment modalities for schizophrenia in the clinical setting
Evaluate the effectiveness of the various treatment modalities for schizophrenia in the clinical setting
Clinical trial (a) There are several methods to assign treatments to patients in comparative clinical trials....
Clinical trial (a) There are several methods to assign treatments to patients in comparative clinical trials. Commonly used methods include pure randomization ,permutted blocks and within strata. Briefly describe each of these technique for which the institution ,the sex,and age of the patient (under 50 years of age versus over 50 years of age) are factors that could be taken into account at the time of randomization.
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 18 subjects had a mean wake time of 103.0 min. After​ treatment, the 18 subjects had a mean wake time of 78.4 min and a standard deviation of 20.7 min. Assume that the 18 sample values appear to be from a normally distributed population and construct a 95 ​% confidence interval estimate of the mean wake time for a population...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 15 subjects had a mean wake time of 105.0 min. After​ treatment, the 15 subjects had a mean wake time of 99.7 min and a standard deviation of 24.3 min. Assume that the 15 sample values appear to be from a normally distributed population and construct a 95​% confidence interval estimate of the mean wake time for a population with...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment,23 subjects had a mean wake time of 104.0 min. After​ treatment, the 23 subjects had a mean wake time of 79.5 min and a standard deviation of 23.92 min. Assume that the 23 sample values appear to be from a normally distributed population and construct a 95​% confidence interval estimate of the mean wake time for a population with drug...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in...
A clinical trial was conducted to test the effectiveness of a drug for treating insomnia in older subjects. Before​ treatment, 2323 subjects had a mean wake time of 100.0100.0 min. After​ treatment, the 2323 subjects had a mean wake time of 74.674.6 min and a standard deviation of 20.920.9 min. Assume that the 2323 sample values appear to be from a normally distributed population and construct a 9999​% confidence interval estimate of the mean wake time for a population with...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT